Randomized, Open-Label, Phase IV Trial in Nucleos(t)ide-Naive Patients With Chronic Hepatitis B to Examine the Effect of Telbivudine Compared to Lamivudine on the Early Dynamics and Kinetics of Viral Suppression (Early-Viral-Dynamics Study).

Trial Profile

Randomized, Open-Label, Phase IV Trial in Nucleos(t)ide-Naive Patients With Chronic Hepatitis B to Examine the Effect of Telbivudine Compared to Lamivudine on the Early Dynamics and Kinetics of Viral Suppression (Early-Viral-Dynamics Study).

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 01 May 2009

At a glance

  • Drugs Lamivudine; Telbivudine
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Acronyms EVD
  • Most Recent Events

    • 01 May 2009 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 15 Jul 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top